[go: up one dir, main page]

GB201911007D0 - CD70 combination therapy - Google Patents

CD70 combination therapy

Info

Publication number
GB201911007D0
GB201911007D0 GBGB1911007.1A GB201911007A GB201911007D0 GB 201911007 D0 GB201911007 D0 GB 201911007D0 GB 201911007 A GB201911007 A GB 201911007A GB 201911007 D0 GB201911007 D0 GB 201911007D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1911007.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Of Bern, University of
ArgenX BVBA
Universitaet Bern
Original Assignee
Of Bern, University of
ArgenX BVBA
Universitaet Bern
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Of Bern, University of, ArgenX BVBA, Universitaet Bern filed Critical Of Bern, University of
Priority to GBGB1911007.1A priority Critical patent/GB201911007D0/en
Publication of GB201911007D0 publication Critical patent/GB201911007D0/en
Priority to TW108146057A priority patent/TWI848030B/en
Priority to UY0001038511A priority patent/UY38511A/en
Priority to EP23151526.3A priority patent/EP4218761A1/en
Priority to KR1020217017438A priority patent/KR20210106428A/en
Priority to HUE19831677A priority patent/HUE061710T2/en
Priority to PL19831677.0T priority patent/PL3890740T3/en
Priority to CN202211004780.8A priority patent/CN115920034A/en
Priority to CN201980082377.7A priority patent/CN113226317B/en
Priority to US16/719,220 priority patent/US11712468B2/en
Priority to PCT/EP2019/085982 priority patent/WO2020127503A1/en
Priority to CA3117282A priority patent/CA3117282A1/en
Priority to PT198316770T priority patent/PT3890740T/en
Priority to ES19831677T priority patent/ES2941638T3/en
Priority to AU2019409936A priority patent/AU2019409936B2/en
Priority to SG11202105197UA priority patent/SG11202105197UA/en
Priority to EP19831677.0A priority patent/EP3890740B1/en
Priority to MX2021007350A priority patent/MX2021007350A/en
Priority to DK19831677.0T priority patent/DK3890740T3/en
Priority to JP2021534948A priority patent/JP7565921B2/en
Priority to FIEP19831677.0T priority patent/FI3890740T3/en
Priority to BR112021011684A priority patent/BR112021011684A2/en
Priority to LTEPPCT/EP2019/085982T priority patent/LT3890740T/en
Priority to IL284015A priority patent/IL284015B2/en
Priority to US18/334,582 priority patent/US20240033353A1/en
Priority to JP2024171921A priority patent/JP2025000862A/en
Priority to US19/030,495 priority patent/US20250152707A1/en
Priority to AU2025259981A priority patent/AU2025259981A1/en
Ceased legal-status Critical Current

Links

GBGB1911007.1A 2018-12-18 2019-08-01 CD70 combination therapy Ceased GB201911007D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GBGB1911007.1A GB201911007D0 (en) 2019-08-01 2019-08-01 CD70 combination therapy
TW108146057A TWI848030B (en) 2018-12-18 2019-12-16 CD70 combination therapy
UY0001038511A UY38511A (en) 2018-12-18 2019-12-17 COMBINATION THERAPY CD70
IL284015A IL284015B2 (en) 2018-12-18 2019-12-18 Combination of CD70 and Ventoclax for the treatment of acute myeloid leukemia
PT198316770T PT3890740T (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
EP19831677.0A EP3890740B1 (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
HUE19831677A HUE061710T2 (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
PL19831677.0T PL3890740T3 (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
CN202211004780.8A CN115920034A (en) 2018-12-18 2019-12-18 Combination therapy of CD70 and BCL-2 inhibitors for the treatment of acute myelogenous leukemia
CN201980082377.7A CN113226317B (en) 2018-12-18 2019-12-18 Combination therapy of CD70 and Venacla as BCL-2 inhibitor for the treatment of acute myeloid leukemia
US16/719,220 US11712468B2 (en) 2018-12-18 2019-12-18 CD70 combination therapy
PCT/EP2019/085982 WO2020127503A1 (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
CA3117282A CA3117282A1 (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
EP23151526.3A EP4218761A1 (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
ES19831677T ES2941638T3 (en) 2018-12-18 2019-12-18 CD70 and venetoclax, a BCL-2 inhibitor, combination therapy for the treatment of acute myeloid leukemia
AU2019409936A AU2019409936B2 (en) 2018-12-18 2019-12-18 CD70 and venetoclax, a BCL-2 inhibitor, combination therapy for treating acute myeloid leukemia
SG11202105197UA SG11202105197UA (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
KR1020217017438A KR20210106428A (en) 2018-12-18 2019-12-18 BCL-2 inhibitor, CD70 and venetoclax combination therapy for the treatment of acute myeloid leukemia
MX2021007350A MX2021007350A (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia.
DK19831677.0T DK3890740T3 (en) 2018-12-18 2019-12-18 CD70 and venetoclax, a BCL-2 inhibitor, combination therapy for the treatment of acute myeloid leukemia
JP2021534948A JP7565921B2 (en) 2018-12-18 2019-12-18 CD70 and venetoclax, a BCL-2 inhibitor, combination therapy for the treatment of acute myeloid leukemia
FIEP19831677.0T FI3890740T3 (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
BR112021011684A BR112021011684A2 (en) 2018-12-18 2019-12-18 Combination Therapy With CD70 and Venetoclax, a Bcl-2 Inhibitor, for the Treatment of Acute Myeloid Leukemia
LTEPPCT/EP2019/085982T LT3890740T (en) 2018-12-18 2019-12-18 Cd70 and venetoclax, a bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
US18/334,582 US20240033353A1 (en) 2018-12-18 2023-06-14 Cd70 combination therapy
JP2024171921A JP2025000862A (en) 2018-12-18 2024-10-01 Cd70 and venetoclax, bcl-2 inhibitor, combination therapy for treating acute myeloid leukemia
US19/030,495 US20250152707A1 (en) 2018-12-18 2025-01-17 Cd70 combination therapy
AU2025259981A AU2025259981A1 (en) 2018-12-18 2025-10-31 CD70 and venetoclax, a BCL-2 inhibitor, combination therapy for treating acute myeloid leukemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1911007.1A GB201911007D0 (en) 2019-08-01 2019-08-01 CD70 combination therapy

Publications (1)

Publication Number Publication Date
GB201911007D0 true GB201911007D0 (en) 2019-09-18

Family

ID=67990645

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1911007.1A Ceased GB201911007D0 (en) 2018-12-18 2019-08-01 CD70 combination therapy

Country Status (1)

Country Link
GB (1) GB201911007D0 (en)

Similar Documents

Publication Publication Date Title
IL276103A (en) Cd70 combination therapy
IL277336A (en) Combination therapy
GB201900702D0 (en) Therapy
IL280729A (en) Combination therapy
IL279908A (en) Combination therapy
ZA202200731B (en) Combination therapy
IL288237A (en) Combination therapy
GB201918752D0 (en) New therapy
GB201912191D0 (en) New therapy
GB201914006D0 (en) Combination Therapy
GB201910473D0 (en) Combination therapy
GB201906864D0 (en) Combination therapy
GB201917701D0 (en) CD70 Combination therapy
GB201911007D0 (en) CD70 combination therapy
GB201820582D0 (en) CD70 combination therapy
GB201919301D0 (en) Combination therapy
GB201917254D0 (en) Combination therapy
GB201908225D0 (en) Combination therapy
GB201908227D0 (en) Combination therapy
GB201908234D0 (en) Combination therapy
GB201908233D0 (en) Combination therapy
GB201908232D0 (en) Combination Therapy
GB201908231D0 (en) Combination therapy
GB201906867D0 (en) Combination therapy
GB201906862D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)